Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection-Reference-Cited by-同舟云学术

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

Published:1998-03 Issue:9105 Volume:351 Page:786-792
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Halsey Neal A,Coberly Jacqueline S,Desormeaux Julio,Losikoff Phyllis,Atkinson Joan,Moulton Lawrence H,Contave Mireil,Johnson Michael,Davis Homer,Geiter Lawrence,Johnson Erica,Huebner Robin,Boulos Reginald,Chaisson Richard E

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection;Selwyn;N Engl J Med,1989

2. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women;Allen;Am Rev Respir Dis,1992

3. Incidence of tuberculosis in the United States among HIV-Infected persons;Markowitz;Ann Intern Med,1997

4. A prospective study of the risk of tuberculosis among HIV-1 infected patients;Guelar;AIDS,1993

5. Controlled chemoprophylaxis trials in tuberculosis: a general review;Ferebee;Adv Tuberc Res,1970

Cited by 230 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Network Pharmacology Approach to Evaluate Bioactive Phytochemicals of Acalypha indica and Their Mechanistic Actions to Suppress Target Genes of Tuberculosis;ACS Omega;2023-12-29

2. Chapitre 6: Le traitement préventif de la tuberculose chez les adultes;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-11-02

3. Converging Epidemics: A Narrative Review of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) Coinfection;Cureus;2023-10-25

4. Landscape of TB Infection and Prevention among People Living with HIV;Pathogens;2022-12-16

5. Efficacy, safety, and tolerability of isoniazid preventive therapy for tuberculosis in people living with HIV;AIDS;2022-11-22